AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 145 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $62,000 | +376.9% | 4,120 | +172.5% | 0.00% | – |
| Q1 2022 | $13,000 | -23.5% | 1,512 | -40.2% | 0.00% | – |
| Q4 2021 | $17,000 | +41.7% | 2,527 | +234.3% | 0.00% | – |
| Q3 2021 | $12,000 | +20.0% | 756 | +15.2% | 0.00% | – |
| Q2 2021 | $10,000 | -33.3% | 656 | -25.6% | 0.00% | – |
| Q1 2021 | $15,000 | -83.7% | 882 | -88.8% | 0.00% | – |
| Q3 2020 | $92,000 | +736.4% | 7,864 | +873.3% | 0.00% | – |
| Q2 2020 | $11,000 | -81.7% | 808 | -82.1% | 0.00% | – |
| Q1 2020 | $60,000 | -73.9% | 4,516 | -62.4% | 0.00% | -100.0% |
| Q3 2019 | $230,000 | -70.7% | 12,009 | -54.9% | 0.00% | -50.0% |
| Q2 2019 | $786,000 | -32.1% | 26,613 | +9.1% | 0.00% | -33.3% |
| Q1 2019 | $1,158,000 | +186.6% | 24,395 | +117.6% | 0.00% | +200.0% |
| Q4 2018 | $404,000 | -69.5% | 11,209 | -48.0% | 0.00% | -75.0% |
| Q3 2018 | $1,326,000 | +155.5% | 21,553 | +180.1% | 0.00% | +100.0% |
| Q2 2018 | $519,000 | +440.6% | 7,696 | +334.3% | 0.00% | -50.0% |
| Q1 2018 | $96,000 | +37.1% | 1,772 | +32.1% | 0.00% | +33.3% |
| Q2 2017 | $70,000 | -81.7% | 1,341 | -84.2% | 0.00% | -82.4% |
| Q1 2017 | $383,000 | +38.8% | 8,466 | +16.0% | 0.02% | +6.2% |
| Q4 2016 | $276,000 | -63.4% | 7,297 | -63.5% | 0.02% | -68.6% |
| Q3 2016 | $754,000 | +9325.0% | 19,988 | +3811.5% | 0.05% | +5000.0% |
| Q2 2016 | $8,000 | -96.0% | 511 | -95.5% | 0.00% | -93.3% |
| Q3 2015 | $199,000 | -84.0% | 11,240 | -84.0% | 0.02% | -85.6% |
| Q2 2015 | $1,242,000 | – | 70,424 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |